Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NRIX

Nurix Therapeutics Inc

Jun 18 • 04:00PM ET

17.55

+0.43 2.51 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYMR RCUS TNGX CGON NUVL RYTM BMRN INCY KRYS AXSM

| Held by: VTI XBI IWM ARKG VXF IWN IBB VTWO SCHA DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.16	Insider Own	5.31%	Shs Outstand	103.40M	Perf Week	3.36%
Market Cap	1.81B	Forward P/E	-	EPS next Y	-2.39	Insider Trans	-1.65%	Shs Float	97.89M	Perf Month	15.16%
Enterprise Value	1.33B	PEG	-	EPS next Q	-0.72	Inst Own	108.36%	Short Float	19.74%	Perf Quarter	17.63%
Income	-295.28M	P/S	25.28	EPS this Y	17.94%	Inst Trans	2.51%	Short Ratio	11.05	Perf Half Y	-6.85%
Sales	71.78M	P/B	3.77	EPS next Y	4.57%	ROA	-47.20%	Short Interest	19.32M	Perf YTD	-7.49%
Book/sh	4.65	P/C	3.36	EPS next 5Y	20.61%	ROE	-61.40%	52W High	22.50 -22.00%	Perf Year	51.03%
Cash/sh	5.23	P/FCF	-	EPS past 3/5Y	6.31% -2.04%	ROIC	-55.05%	52W Low	8.19 114.15%	Perf 3Y	61.16%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	29.55% 36.35%	Gross Margin	74.22%	Volatility	7.04% 7.51%	Perf 5Y	-39.36%
Dividend TTM	-	EV/Sales	18.57	EPS Y/Y TTM	-12.53%	Oper. Margin	-439.26%	ATR (14)	1.18	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.01	Sales Y/Y TTM	27.23%	Profit Margin	-411.37%	RSI (14)	59.79	Recom	1.19
Dividend Gr. 3/5Y	- -	Current Ratio	6.01	EPS Q/Q	-17.44%	SMA20	5.17%	Beta	1.87	Target Price	31.44
Payout	-	Debt/Eq	0.12	Sales Q/Q	-66.12%	SMA50	6.09%	Rel Volume	2.43	Prev Close	17.12
Employees	317	LT Debt/Eq	0.12	Earnings	Apr 08 BMO	SMA200	16.40%	Avg Volume	1.75M	Price	17.55
IPO	Jul 24, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-3.59% -56.13%	Trades		Volume	4,241,496	Change	2.51%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)